Skip to main content

Basil Michelle L's Form 4 filing

Haemonetics Corp (HAE) · filed Sep 21, 2022

Accession no.
0001127602-22-022782
Filed
Sep 21, 2022
Trade date
Sep 19, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $897.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Basil Michelle LCIK 0001699629Officer (EVP and General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 19, 2022Common StockMOption exerciseAcquired+3,464$38.43+$133,121.5238,859Direct
Sep 19, 2022Common StockMOption exerciseAcquired+4,213$41.64+$175,429.3243,072Direct
Sep 19, 2022Common StockMOption exerciseAcquired+1,011$56.57+$57,192.2744,083Direct
Sep 19, 2022Common StockSSaleDisposed−11,448$78.36−$897,065.2832,635Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 19, 2022Common StockMOption exerciseDisposed−3,464$0.00$00Direct
Sep 19, 2022Common StockMOption exerciseDisposed−4,213$0.00$00Direct
Sep 19, 2022Common StockMOption exerciseDisposed−1,011$0.00$012,553Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)